SIGKNOW BIOMEDICAL CO., LTD.
Booth No: M905
Sigknow Biomedical’s EZYPRO®-the solution to increase arrhythmia detection rate, incorporates both the 14-day continuous recording ECG and the AI machining learning ECG analysis software. EZYPRO®-Asia’s first non-invasive 14-day continuous ECG recorder, is resistant to water and sweat, mild to the skin, and conveniently ambulatory. Post-market research demonstrates that EZYPRO® increases user compliance, leading to a ~ 60% diagnosis rate of arrhythmia that is 3 to 5 times greater than Holter's.
Exhibitors you may be interested in